DEXCOM INC (DXCM) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $2.75B | +30.6% |
| 2024 | $2.10B | +1.6% |
| 2023 | $2.07B | -3.0% |
| 2022 | $2.13B | +4.4% |
| 2021 | $2.04B | +31.6% |
| 2020 | $1.55B | +75.8% |
| 2019 | $882.60M | +33.1% |
| 2018 | $663.30M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $2.75B | +30.6% |
| 2024 | $2.10B | +1.6% |
| 2023 | $2.07B | -3.0% |
| 2022 | $2.13B | +4.4% |
| 2021 | $2.04B | +31.6% |
| 2020 | $1.55B | +75.8% |
| 2019 | $882.60M | +33.1% |
| 2018 | $663.30M | — |